These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4710779)

  • 1. Effects of LSD-25 and dextroamphetamine on speech rhythms in psychotherapy dialogues.
    Jaffe J; Dahlberg CC; Luria J; Chorosh J
    Biol Psychiatry; 1973 Feb; 6(1):93-6. PubMed ID: 4710779
    [No Abstract]   [Full Text] [Related]  

  • 2. Speech rhythms in patient monologues: the influence of LSD-25 and dextroamphetamine.
    Jaffe J; Dahlberg CC; Luria J; Breskin S; Chorosh J; Lorick E
    Biol Psychiatry; 1972 Jun; 4(3):243-6. PubMed ID: 5041919
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of psychotomimetics on therapist--patient matching of speech "rhythms".
    Natale M; Dahlberg CC; Jaffe J
    J Commun Disord; 1979 Feb; 12(1):45-52. PubMed ID: 370160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of LSD-25 and dextroamphetamine on the use of defensive language.
    Dahlberg CC; Jaffe J
    J Clin Psychol; 1979 Apr; 35(2):250-4. PubMed ID: 457881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of psychotomimetics (LSD and dextroamphetamine) on the use of primary- and secondary-process language.
    Natale M; Dahlberg CC; Jaffe J
    J Consult Clin Psychol; 1978 Apr; 46(2):352-3. PubMed ID: 649815
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of psychotomimetics (LSD and dextroamphetamine) on the use of figurative language during psychoanalysis.
    Natale M; Kowitt M; Dahlberg CC; Jaffe J
    J Consult Clin Psychol; 1978 Dec; 46(6):1579-80. PubMed ID: 730927
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetmine in alcoholics.
    Hollister LE; Shelton J; Krieger G
    Am J Psychiatry; 1969 Apr; 125(10):1352-7. PubMed ID: 4886242
    [No Abstract]   [Full Text] [Related]  

  • 9. D-amphetamine as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Eur J Pharmacol; 1973 Feb; 21(2):212-6. PubMed ID: 4696103
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of lysergic acid diethylamide (LSD-25) in obsessive neuroses].
    DAVID JM
    Sem Med; 1960 Oct; 117():1373-84. PubMed ID: 13719995
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of effects of LSD and amphetamine on midbrain raphe units.
    Foote WE; Sheard MH; Aghajanian GK
    Nature; 1969 May; 222(5193):567-9. PubMed ID: 5781659
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.
    Gasser P; Holstein D; Michel Y; Doblin R; Yazar-Klosinski B; Passie T; Brenneisen R
    J Nerv Ment Dis; 2014 Jul; 202(7):513-20. PubMed ID: 24594678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lysergic acid diethylamide (LSD) on temporal recovery (pre-pulse inhibition) of the acoustic startle response in the rat.
    Davis M; Sheard MH
    Pharmacol Biochem Behav; 1975; 3(5):861-8. PubMed ID: 1208627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variable effects of LSD-25 on the behavior of a heterogeneous group of childhood schizophrenics.
    Simmons JQ; Benor D; Daniel D
    Behav Neuropsychiatry; 1972; 4(1-2):10-6 passim. PubMed ID: 5040232
    [No Abstract]   [Full Text] [Related]  

  • 15. Lysergic acid diethylamide tartrate (LSD-25) dosage levels, group differences and social interaction.
    Cheek FE; Holstein CM
    J Nerv Ment Dis; 1971 Aug; 153(2):133-47. PubMed ID: 5572106
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ist European symposium for psychotherapy under the influence of LSD-25, Goettingen, November 1960].
    BAROLIN GS
    Wien Med Wochenschr; 1961 Jul; 111():466-8. PubMed ID: 13687173
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.
    Abramson HA; Rolo A
    J Asthma Res; 1965 Sep; 3(1):81-96. PubMed ID: 5318626
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of LSD, mescaline, and D-amphetamine on the evoked "secondary discharge".
    Roth WT
    Psychopharmacologia; 1966; 9(3):253-8. PubMed ID: 6010545
    [No Abstract]   [Full Text] [Related]  

  • 19. The neurophysiological basis of hypnosis--objective techniques.
    Ulett GA; Akpinar S; Itil TM; Fukuda T
    Folia Psychiatr Neurol Jpn; 1971; 25(3):203-11. PubMed ID: 5172594
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of phencyclidine, LSD and amphetamine on neuronal activity in the posterior parietal association cortex of the monkey.
    Hyvärinen J; Laakso M; Roine R; Leinonen L
    Neuropharmacology; 1979 Mar; 18(3):237-42. PubMed ID: 108607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.